Detection of numerical alterations of chromosomes 3, 7, 17 and X in low-grade intracystic papillary tumors of the breast by multi-color fluorescence in Situ hybridization

Breast Cancer

Volumn 4, Issue 4, 1997, Pages 247-252

  Tsuda, Hitoshi ^a   Takarabe, Teruko ^a   Inazawa, Johji ^b   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Chromosomal alterations; Fluorescence in situ hybridization; Papillary tumors of the breast

Indexed keywords

EID: 13244262314     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966515     Document Type: Conference Paper

References (18)

1. Koss LG, Zajicek J: Aspiration biopsy. In: Koss LG ed, Diagnostic Cytology and Its Histopathologic Bases, vol 2, 4th ed, JB Lippincott Co, Philadelphia, pp1293-1315, 1992.
2. Kraus FT, Neubecker RD: The differential diagnosis of papillary carcinoma of the breast. Cancer 15:444-455, 1962.
3. Carter D, Orr SL, Marino M J: Intracystic papillary carcinoma of the breast; After mastectomy, radiotherapy or excisional biopsy alone. Cancer 52:14-19, 1983. (Pubitemid 13061316)
4. Page DL, Anderson T J: Diagnostic Histopathology of the Breast, Churchill Livingstone, Edinburgh, pp104-119, 196-190, 1987.
5. Sato T, Tanigami A, Yamakawa K, et al: Allelotype of breast cancer; Cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50:7184-7189, 1990.
6. Bieche I, Lidereau R: Genetic alterations in breast cancer. Genes Chromosomes Cancer 14:227-251, 1995.
7. Murphy DS, Hoare SF, Going J J, et al: Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst 87:1694-1704, 1995.
8. Tsuda H, Uei Y, Fukutomi T, et al: Different incidence of loss of heterozygosity on chromosome 16q between intraductal papilloma and intracystic papillary carcinoma of the breast. Jpn J Cancer Res 85:992-996, 1994. (Pubitemid 24325018)
9. Tsuda H, Takarabe T, Susumu H, et al: Detection of numerical and structural alterations and fusion of chromosomes 16 and 1 in low-grade papillary breast carcinoma by fluorescence in situ hybridization. Am J Pathol 151:1027-1034, 1997. (Pubitemid 27424312)
10. Devilee P, Thierry RF, Kievits T, et al: Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosomespecific repetitive DNA probes. Cancer Res 48:5825-5830, 1988.
11. Genuardi M, Tsihira H, Anderson DE, et al: Distal deletion of chromosome lp in ductal carcinoma of the breast. Am J Human Genet 45:73-82, 1989. (Pubitemid 19178523)
12. Devilee P, van Vliet M, Bardoel A, et al: Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res 51: 1020-1025, 1991.
13. Ichikawa D, Hashimoto N, Hoshima M, et al: Analysis of numerical aberrations in specific chromosomes by fluorescence in situ hybridization (FISH) as a diagnostic tool in breast cancer. Cancer 77:2064-2069, 1996. (Pubitemid 26142050)
14. Kondoleon S, Vissing H, Luo XY, et al: A hypervariable RFLP on chromosome 17p13 defined by an arbitrary single copy probe p144-D6. Nucleic Acids Res 15:10605, 1987.
15. Inazawa J, Saito H, Ariyama T, et al: High-resolution cytogenetic mapping of 342 new cosmid markers including 43 RFLP markers on human chromosome 17 by fluorescence in situ hybridization. Genomics 17:153-162, 1993. (Pubitemid 23205072)
16. Warburton PE, Greig GM, Haaf T, et al: PCR amplification of chromosome-specific alpha satellite DNA; Definition of centromeric STS markers and polymorphic analysis. Genomics 11:324-333, 1991.
17. Chen L-C, Neubauer A, Kurisu W, et al: Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer. Proe Natl Acad Sci USA 88:3847-3851, 1991. (Pubitemid 21916721)
18. Merlo GR, Venesio T, Bernardi A, et al: Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index. Am J Pathol 140:215-223, 1992.